5AM Venture Management, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
5AM Venture Management, LLC disclosed 28 US equity positions worth $484.0m in its Q3 2024 13F filing. The largest position was TRDA at 14.6% of the reported book, followed by ELVN and SKYE.
What did 5AM Venture Management, LLC own in Q3 2024? Top 28 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | TRDA ENTRADA THERAPEUTICS INC | 14.6% | $70.4m | 4,408,379 | – | ||
| 2 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 9.2% | $44.8m | 1,752,174 | – | |
| 3 | SKYE SKYE BIOSCIENCE INC | 8.0% | $38.8m | 9,913,168 | – | ||
| 4 | ARTV ARTIVA BIOTHERAPEUTICS INC | 7.5% | $36.4m | 2,353,304 | – | ||
| 5 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 7.0% | $33.7m | 1,231,619 | – | |
| 6 | BHVN BIOHAVEN LTD | Healthcare | 4.9% | $23.9m | 478,972 | – | |
| 7 | TYRA TYRA BIOSCIENCES INC | Healthcare | 4.6% | $22.1m | 939,298 | – | |
| 8 | CNTA CENTESSA PHARMACEUTICALS PLC | 4.2% | $20.5m | 1,285,000 | – | ||
| 9 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 4.0% | $19.6m | 646,524 | – | |
| 10 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 4.0% | $19.6m | 340,000 | – | |
| 11 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 3.5% | $16.9m | 497,270 | – | |
| 12 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 3.5% | $16.8m | 736,595 | – | |
| 13 | VKTX VIKING THERAPEUTICS INC | Healthcare | 3.1% | $15.0m | 237,560 | – | |
| 14 | PHVS PHARVARIS N V | 3.1% | $14.8m | 797,600 | – | ||
| 15 | ERAS ERASCA INC | Healthcare | 3.0% | $14.8m | 5,405,404 | – | |
| 16 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 2.9% | $14.2m | 282,313 | – | |
| 17 | ANAB ANAPTYSBIO INC | Healthcare | 2.5% | $12.0m | 357,733 | – | |
| 18 | SLN SILENCE THERAPEUTICS PLC | 1.8% | $8.7m | 476,200 | – | ||
| 19 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.7% | $8.4m | 1,050,000 | – | |
| 20 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.3% | $6.1m | 561,854 | – | |
| 21 | SCPH SCPHARMACEUTICALS INC | 1.1% | $5.5m | 1,200,647 | – | ||
| 22 | VOR VOR BIOPHARMA INC | 0.9% | $4.5m | 6,361,723 | – | ||
| 23 | RLYB RALLYBIO CORP | 0.9% | $4.2m | 3,630,724 | – | ||
| 24 | GHRS GH RESEARCH PLC | 0.8% | $3.8m | 572,665 | – | ||
| 25 | AVU0 ADVERUM BIOTECHNOLOGIES INC | 0.8% | $3.8m | 541,666 | – | ||
| 26 | MERSANA THERAPEUTICS INC | 0.5% | $2.5m | 1,305,000 | – | ||
| 27 | ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 0.4% | $1.8m | 490,000 | – | |
| 28 | CDTX CIDARA THERAPEUTICS INC | 0.1% | $609.8k | 56,725 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.